Developments in genomics have already been translated into personalised medicine and more effective treatments for rare diseases. National governments and companies are also investing in data-driven innovation that facilitates these prospects. To help companies access and take advantage of the wealth of data, ELIXIR organised a two-day ELIXIR Innovation and SME Forum on 14-15 November 2017 in Paris, France. The event attracted 75 participants working in large companies, SMEs, academia, patient associations, and European and French government agencies. Read more.
Ask FemkeContact Femke